PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29663513-0	2018	A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.	repaglinide	65-76	G protein-coupled receptor kinase 5	Homo sapiens	13-17	
29663513-1	2018	Post-Market Research We aimed to investigate the impact of G protein-coupled receptor kinase 5 (GRK5) rs10886471 polymorphism on repaglinide efficacy in Chinese patients with type 2 diabetes mellitus (T2DM).	repaglinide	129-140	G protein-coupled receptor kinase 5	Homo sapiens	59-94	
29663513-1	2018	Post-Market Research We aimed to investigate the impact of G protein-coupled receptor kinase 5 (GRK5) rs10886471 polymorphism on repaglinide efficacy in Chinese patients with type 2 diabetes mellitus (T2DM).	repaglinide	129-140	G protein-coupled receptor kinase 5	Homo sapiens	96-100	
29663513-8	2018	These findings suggest that GRK5 rs10886471 polymorphism may influence the therapeutic efficacy of repaglinide in Chinese Han T2DM patients.	repaglinide	99-110	G protein-coupled receptor kinase 5	Homo sapiens	28-32